We are live on ! Find out more
BCAB icon

BioAtla
BCAB

87 hedge funds and large institutions have $96.1M invested in BioAtla in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 13

90% more call options, than puts

Call options by funds: $55K | Put options by funds: $29K

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

10% more funds holding

Funds holding: 79 → 87 (+8)

10% more capital invested

Capital invested by funds: $87.6M → $96.1M (+$8.51M)

0.03% less ownership

Funds ownership: 1.37% → 1.34% (-0.03%)

Holders
87
Holders Change
+8
Holders Change %
+10.13%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
28
Reduced
13
Closed
19
Calls
$55K
Puts
$29K
Net Calls
+$26K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.62M
2
State Street
State Street
Massachusetts
+$1.99M
3
Norges Bank
Norges Bank
Norway
+$1.68M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.57M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$9.3M
2
CS
Candriam SCA
Luxembourg
-$3.86M
3
APM
Avidity Partners Management
Texas
-$1.61M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.31M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$979K
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
51
MetLife Investment Management
New Jersey
$74.9K +$86K +500 New
UBS Group
52
UBS Group
Switzerland
$73.8K +$84.6K +492 New
Commonwealth Equity Services
53
Commonwealth Equity Services
Massachusetts
$65K – – –
SHFA
54
SC&H Financial Advisors
Maryland
$64.2K – – –
AIG
55
American International Group
New York
$63.9K +$73.3K +426 New
AG
56
Algert Global
California
$63K +$18.7K +109 +35%
Bank of America
57
Bank of America
North Carolina
$62.4K +$2.75K +16 +4%
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$62.2K +$17.2K +100 +45%
Manulife (Manufacturers Life Insurance)
59
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$58.2K +$66.7K +388 New
American Century Companies
60
American Century Companies
Missouri
$55.5K +$63.6K +370 New
Verition Fund Management
61
Verition Fund Management
Connecticut
$54.9K +$62.9K +366 New
VOYA Investment Management
62
VOYA Investment Management
Georgia
$53.6K +$61.4K +357 New
Invesco
63
Invesco
Georgia
$53.4K +$61.2K +356 New
Wells Fargo
64
Wells Fargo
California
$50.6K +$56.9K +331 +5,517%
PCM
65
Prelude Capital Management
New York
$48K +$10.8K +63 +25%
PFCS
66
Pale Fire Capital SE
Czech Republic
$47.6K +$54.7K +318 New
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$44.1K +$50.6K +294 New
Citigroup
68
Citigroup
New York
$41.9K +$46.3K +269 +2,445%
HighTower Advisors
69
HighTower Advisors
Illinois
$39K – – –
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$37.7K +$43.2K +251 New
TLCM
71
Twin Lakes Capital Management
California
$31.5K – – –
Barclays
72
Barclays
United Kingdom
$26.5K +$30.4K +177 New
DA
73
Denali Advisors
California
$21.9K – – –
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
$14K +$16K +93 New
TRCT
75
Tower Research Capital (TRC)
New York
$13.9K -$22.9K -133 -59%
1 2
3
4 5

BCAB Hedge Fund Activity: Q2 2023 in Review

87 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2023, worth a combined $96.1M — up 9.7% from $87.6M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BCAB positions and 19 closed out — a net gain of 8 holders — while 28 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $7.62M. The largest seller was OrbiMed, cutting an estimated $9.3M.

  • 87 institutional investors held BioAtla (BCAB) as of Q2 2023, up from 79 in Q1 2023.
  • Funds reported $96.1M of BioAtla stock for Q2 2023, up 9.7% quarter-over-quarter.
  • 27 funds opened new BioAtla positions in Q2 2023 and 19 closed out, a net change of +8 holders.
  • The largest BioAtla buyer in Q2 2023 was BlackRock, an estimated $7.62M added.
  • The largest BioAtla seller in Q2 2023 was OrbiMed, an estimated $9.3M sold.

Based on aggregated 13F filings for Q2 2023.